COI Centro Oncologico Internacional Santa Fe

Mexico City, Mexico CITY (federal District) 01330

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy — Running, not enrolling